Author

T. Loudovaris

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

A. A. Hardikar· 1 shared A. E. Sorensen· 1 shared A. Moreno-Asso· 1 shared A. Nachanekar· 1 shared C. Smith· 1 shared C.-H. Yang· 1 shared D. Ann-Onda· 1 shared D. L. Eizirik· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. A. Hardikar

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Identification and functional validation of human islet microRNAs associated with donor trait

W. K. Wong, I. El-Azzi, A. Nachanekar, E. Alvandi, N. H. Pham, M. Sara, F. Cheng, G. Jiang, A. E. Sorensen, Y. V. Chew, T. Loudovaris, H. E. Thomas, R. C. Ma, W. J. Hawthorne, L. T. Dalgaard, , A. A. Hardikar

The paper identifies human islet microRNAs associated with donor traits and validates their functional role in telomere length and cellular senescence.

bioRxiv · Oct 14, 2022 · PreprintCell Biology

Elevated Neuropeptide Y1 Receptor Signaling Contributes to β-cell Dysfunction and Failure in Type 2 Diabetes

C.-H. Yang, D. Ann-Onda, X. Lin, S. Fynch, S. Nadarajah, E. Pappas, X. Liu, J. Scott, J. S. Oakhill, S. Galic, Y. Shi, A. Moreno-Asso, C. Smith, T. Loudovaris, I. Levinger, , K. Loh

This study shows that increased neuropeptide Y1 receptor signaling contributes to β-cell dysfunction in type 2 diabetes and that inhibiting this receptor with BIBO3304 improves β-cell function and glycaemic control.

bioRxiv · May 14, 2021 · PreprintCell Biology